REGENERON PHARMACEUTICALS
Reported by SOUTHEASTERN ASSET MANAGEMENT INC TN
Reported 144,607 shares, down 15,974 (9.9%) from the prior quarter.
Reported value -3.6%; share count -9.9% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2025-03-31 | 72860344 |
| 2025-06-30 | 84305025 |
| 2025-09-30 | 81308178 |
| 2025-12-31 | 127969871 |
| 2026-03-31 | 100954687 |
| 2026-06-30 | 94978860 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2026 | Added | 152,322 | +21,660 (16.6%) | 4.95% | $94,978,860 | 2026-08-14 | |
| Q1 2026 | Reduced | 130,662 | -35,130 (-21.2%) | 4.97% | $100,954,687 | 2026-05-15 | |
| Q4 2025 | Added | 165,792 | +21,185 (14.7%) | 5.7% | $127,969,871 | 2026-02-13 | |
| Q3 2025 | Reduced | 144,607 | -15,974 (-9.9%) | 4.15% | $81,308,178 | 2025-11-14 | |
| Q2 2025 | Added | 160,581 | +45,701 (39.8%) | 4.25% | $84,305,025 | 2025-08-14 | |
| Q1 2025 | New | 114,880 | +114,880 (0.0%) | 3.88% | $72,860,344 | 2025-05-15 |
Who else reported the position
1358 managers reported REGENERON PHARMACEUTICALS for Q3 2025.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | Reduced | 9,048,269 | -375,779 | 0.08% | $5,087,570,211 | 50 qtrs |
| BlackRock Inc | Reduced | 8,837,174 | -438,911 | 0.09% | $4,968,878,140 | 5 qtrs |
| STATE STREET CORPORATION | Reduced | 4,691,223 | -140,779 | 0.09% | $2,637,733,956 | 50 qtrs |
| Dodge & Cox | Added | 4,550,845 | +724,562 | 1.38% | $2,558,803,618 | 16 qtrs |
| JPMorgan Chase & Co | Added | 4,072,326 | +132,708 | 0.14% | $2,289,760,415 | 50 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 2,535,898 | +70,844 | 0.09% | $1,419,627,369 | 50 qtrs |
| FRANKLIN RESOURCES INC | Added | 2,453,143 | +139,647 | 0.34% | $1,379,328,713 | 50 qtrs |
| Capital World Investors | Added | 1,998,366 | +32,348 | 0.15% | $1,123,608,855 | 50 qtrs |
| LOOMIS SAYLES & CO L P | Added | 1,979,453 | +38,383 | 1.32% | $1,112,987,056 | 37 qtrs |
| FMR LLC | Reduced | 1,935,835 | -1,391,216 | 0.06% | $1,088,462,214 | 50 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2025
- Filed
- November 14, 2025
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 144,607
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.